Literature DB >> 27836942

Species Differences in Human and Rodent PEPT2-Mediated Transport of Glycylsarcosine and Cefadroxil in Pichia Pastoris Transformants.

Feifeng Song1, Yongjun Hu1, Huidi Jiang1, David E Smith2.   

Abstract

The proton-coupled oligopeptide transporter PEPT2 (SLC15A2) plays an important role in the disposition of di/tripeptides and peptide-like drugs in kidney and brain. However, unlike PEPT1 (SLC15A1), there is little information about species differences in the transport of PEPT2-mediated substrates. The purpose of this study was to determine whether PEPT2 exhibited a species-dependent uptake of glycylsarcosine (GlySar) and cefadroxil using yeast Pichia pastoris cells expressing cDNA from human, mouse, and rat. In such a system, the functional activity of PEPT2 was evaluated with [3H]GlySar as a function of time, pH, substrate concentration, and specificity, and with [3H]cefadroxil as a function of concentration. We observed that the uptake of GlySar was pH-dependent with an optimal uptake at pH 6.5 for all three species. Moreover, GlySar showed saturable uptake kinetics, with Km values in human (150.6 µM) > mouse (42.8 µM) ≈ rat (36.0 µM). The PEPT2-mediated uptake of GlySar in yeast transformants was specific, being inhibited by di/tripeptides and peptide-like drugs, but not by amino acids and nonsubstrate compounds. Cefadroxil also showed a saturable uptake profile in all three species, with Km values in human (150.8 μM) > mouse (15.6 μM) ≈ rat (11.9 μM). These findings demonstrated that the PEPT2-mediated uptake of GlySar and cefadroxil was specific, species dependent, and saturable. Furthermore, based on the Km values, mice appeared similar to rats but both were less than optimal as animal models in evaluating the renal reabsorption and pharmacokinetics of peptides and peptide-like drugs in humans.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27836942      PMCID: PMC5267517          DOI: 10.1124/dmd.116.073320

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  42 in total

1.  Real-time PCR-based determination of gene copy numbers in Pichia pastoris.

Authors:  Sandra Abad; Kerstin Kitz; Astrid Hörmann; Ulrike Schreiner; Franz S Hartner; Anton Glieder
Journal:  Biotechnol J       Date:  2010-04       Impact factor: 4.677

2.  Kinetic analyses for species differences in P-glycoprotein-mediated drug transport.

Authors:  Miki Katoh; Naoto Suzuyama; Toshiyuki Takeuchi; Sumie Yoshitomi; Satoru Asahi; Tsuyoshi Yokoi
Journal:  J Pharm Sci       Date:  2006-12       Impact factor: 3.534

Review 3.  Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.

Authors:  Xi-Ling Jiang; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Rev       Date:  2010-09-21       Impact factor: 4.518

4.  Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice.

Authors:  Scott M Ocheltree; Hong Shen; Yongjun Hu; Jianming Xiang; Richard F Keep; David E Smith
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

5.  Comparison of human and monkey peptide transporters: PEPT1 and PEPT2.

Authors:  Eric Y Zhang; Richard M Emerick; Youngeen A Pak; Steven A Wrighton; Kathleen M Hillgren
Journal:  Mol Pharm       Date:  2004 May-Jun       Impact factor: 4.939

6.  Expression of the mammalian renal peptide transporter PEPT2 in the yeast Pichia pastoris and applications of the yeast system for functional analysis.

Authors:  F Döring; T Michel; A Rösel; M Nickolaus; H Daniel
Journal:  Mol Membr Biol       Date:  1998 Apr-Jun       Impact factor: 2.857

Review 7.  Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity.

Authors:  Mohamed A Kamal; Richard F Keep; David E Smith
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

8.  Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter.

Authors:  M Boll; M Herget; M Wagener; W M Weber; D Markovich; J Biber; W Clauss; H Murer; H Daniel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Proton/peptide cotransporter (PEPT 2) from human kidney: functional characterization and chromosomal localization.

Authors:  S Ramamoorthy; W Liu; Y Y Ma; T L Yang-Feng; V Ganapathy; F H Leibach
Journal:  Biochim Biophys Acta       Date:  1995-11-22

Review 10.  Genetically humanized mouse models of drug metabolizing enzymes and transporters and their applications.

Authors:  Nico Scheer; C Roland Wolf
Journal:  Xenobiotica       Date:  2013-07-11       Impact factor: 1.908

View more
  3 in total

Review 1.  Choroid Plexus and Drug Removal Mechanisms.

Authors:  Austin Sun; Joanne Wang
Journal:  AAPS J       Date:  2021-05-03       Impact factor: 4.009

2.  Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells.

Authors:  Feifeng Song; Yongjun Hu; Yuqing Wang; David E Smith; Huidi Jiang
Journal:  Mol Pharm       Date:  2018-01-02       Impact factor: 4.939

Review 3.  Heterologous (Over) Expression of Human SoLute Carrier (SLC) in Yeast: A Well-Recognized Tool for Human Transporter Function/Structure Studies.

Authors:  Lorena Pochini; Michele Galluccio
Journal:  Life (Basel)       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.